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SHORT COMMUNICATION

Precipitating Factors of Hepatic
Encephalopathy in Patients with
Chronic Liver Disease at Civil
Hospital Karachi

factor of hepatic encephalopathy. The results are
summarized in Table I. Infections including spontaneous
bacterial peritonitis were noted to be the major inciting
stimuli for precipitating hepatic encephalopathy. Among
the drug-precipitated hepatic encephalopathy patients,
frusemide and propranolol were identified as the likely
culprits.

Dileep K. Rohra1, Jaipal2, Ameer A. Khowaja1, Khalid
Mahmood2 and Kanya Lal Ahuja1

Table I: Most likely participating factor for hepatic encephalopathy.
Most likely precipitating factor

Patients with chronic liver disease (CLD) constitute a
significant burden on the economy of the country.
Approximately 3% of global population is estimated to
be chronically infected with hepatitis C virus with an
annual incidence of 3 to 4 million new cases globally.1
Patients with CLD frequently experience episodes of
exacerbations including hepatic encephalopathy
precipitated by variety of established precipitants.2
Hepatic encephalopathy is defined as a spectrum of
neuropsychiatric abnormalities in patients with liver
dysfunction, after exclusion of other known brain
disease.2 It is characterized by personality changes,
intellectual impairment, and a depressed level of
consciousness. Identification of the precipitants and their
prevention and/or immediate seeking of tertiary care
facility may have significant impact on morbidity
and mortality of patients presenting with hepatic
encephalopathy. The objective of this study was to
determine the frequency of factors likely to precipitate the
hepatic encephalopathy in patients with CLD presenting
to the Medical Wards of Civil Hospital, Karachi.
Patients admitted to Medical Wards at Civil Hospital,
Karachi, from August 1, 2006 to December 31, 2006
were selected. Inclusion criteria included those patients
who already had the established diagnosis of CLD on
the basis of history, physical examination, laboratory,
and radiological tests. The diagnosis of the hepatic
encephalopathy and the likely precipitating factor was
made by the Incharge of the ward. Once, the patients
became stabilized, they were also interviewed in order
to know more about the precipitating factor.
Two hundred fifty-six patients with CLD were recruited in
this study to determine the most likely precipitating
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Frequency

%

Gastrointestinal bleeding

39

15.2

Constipation

31

12.1

Spontaneous Bacterial Peritonitis (SBP)

28

10.9

Infections other than SBP

23

9.0

4

1.6

Drugs
Other

1

0.4

Not known

130

50.8

Total

256

100.0

Hepatic encephalopathy is a complicated disorder,
the pathophysiology of which remains to be fully
understood. Current common theories explaining
hepatic encephalopathy include the potential
involvement of ammonia, gamma-aminobutyric acid/
benzodiazipines and false neurotransmitters.3 On most
occasions, hepatic encephalopathy appears due to a
superimposed precipitating factor (gastrointestinal
bleeding, infections, renal and electrolyte disturbances,
etc.).4 In addition to other things, elimination or
treatment of the precipitating factors remains an
important therapeutic goal. Earliest possible diagnosis
and timely intervention is at the core of management
and prevention of progression of CLD. Awareness about
the nature and frequency of precipitating factors to not
only health care professionals but also to patient
population with their subsequent avoidance can
contribute significantly in preventing the disease
progression and episodes of exacerbation. Since
specific precipitating factors have specific treatment,
prompt identification of particular precipitating factor is a
must to prolong the life expectancy and to improve the
quality of life of patients with hepatic encephalopathy.5
This may provide some mortality benefit and may also
improve
the quality of lives of patients suffering from
CLD.
This study, is the first of its kind in Pakistan to show the
frequency of the precipitating factors of hepatic
encephalopathy in patients with CLD. This may help
physician in setting their priorities while managing
patients with hepatic encephalopathy.
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